GLP-1 Agonists and Skin Reactions: What Dermatologists Should Know GLP-1 agonists are widely used for diabetes and weight management, but how do they impact the skin? This study reviews cutaneous…
Read More
Dupilumab for Refractory Hailey-Hailey Disease Hailey-Hailey disease (HHD) is a challenging chronic skin disorder marked by painful blisters and erosions. Treatment can be difficult, with many patients experiencing recurrent flare-ups despite…
Read More
Could GLP-1 Agonists Offer a New Approach to Hidradenitis Suppurativa? Hidradenitis Suppurativa (HS) is a challenging inflammatory skin condition often linked to obesity and metabolic dysfunction. With GLP-1 agonists gaining attention…
Read More
Spotlight on Rosacea: Beyond the Redness This National Rosacea Month April marks National Rosacea Month, a timely reminder for dermatology professionals to sharpen their diagnostic lens beyond textbook erythema. While…
Read More
Life's an itch sometimes….am I right? Pruritus can pick apart the fabric of one’s life as both a symptom of a primary skin disease or even as a disease unto…
Read More
Listen Now! Dermatology is always evolving, and if you haven’t caught the latest "Ask the Investigator" podcast episodes, you're missing out on game-changing insights! Hosted by the always-engaging Dr. Adam…
Read More
Featured Podcast Life's an itch sometimes….am I right? Pruritus can pick apart the fabric of one's life as both a symptom of a primary skin disease or even as a…
Read More
Looking for images for your next lecture or presentation? We’ve got you covered! In dermatology, accurate diagnosis and treatment rely heavily on recognizing how conditions present across diverse skin tones.…
Read More
Featured Podcast Even in a world of exponentially expanding systemic options both on and off label, one fact remains: topical therapy is ALWAYS on the menu. With an unprecedented array…
Read More
Even in a world of exponentially expanding systemic options both on and off label, one fact remains: topical therapy is ALWAYS on the menu. With an unprecedented array of nonsteroidal…
Read More
Did you miss this March article? Generalized pustular psoriasis (GPP) is a serious and unpredictable skin condition with limited treatment options. The Effisayil 1 trial evaluated spesolimab, a monoclonal antibody…
Read More
Prioritizing Skincare in Cancer Treatment: A Latin American Initiative Cancer treatments often lead to skin-related side effects that impact quality of life and, in some cases, treatment adherence. The Latin…
Read More
